Via libera dall’FDA al farmaco prodotto da Mylan La Food and Drug Administration (FDA) degli Stati Uniti ha approvato il primo generico, terapeuticamente equivalente, di dimetilfumarato in capsule a rilascio ritardato. Lo ha annunciato Mylan,…
28 Settembre 2020
Il sito Neurologia Italiana è una testata registrata presso il Tribunale di Milano, 111 del 5/10/2020
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.